作者
Motoi Kondo, Hirofumi Yamamoto, Hiroaki Nagano, Jiro Okami, Yasuhiro Ito, Junzo Shimizu, Hidetoshi Eguchi, Atsushi Miyamoto, Keizo Dono, Koji Umeshita, Nariaki Matsuura, Ken-ichi Wakasa, Shoji Nakamori, Masato Sakon, Morito Monden
发表日期
1999/12/1
期刊
Clinical cancer research
卷号
5
期号
12
页码范围
4005-4012
出版商
American Association for Cancer Research
简介
Recent studies have shown increased levels of cyclooxygenase-2 (COX-2) in a variety of human malignancies including hepatocellular carcinoma (HCC), but little is known about the prognostic value of COX-2 in HCC or its associated nontumor liver tissue. We examined the expression of COX-2 protein by immunohistochemistry in 53 patients with HCCs whose corresponding nontumor tissues were hepatitis C virus-related chronic hepatitis (n = 21) and cirrhosis (n = 32). Samples of nine histologically normal livers and eight precancerous dysplasias were also analyzed. The level of COX-2 increased from normal liver to chronic hepatitis to cirrhosis. The majority of cirrhotic livers (81%) displayed marked COX-2 expression. In dysplasias, COX-2 expression was mainly moderate or strong (88%). In HCC, 17% of samples displayed a high COX-2 expression, and 37% of samples expressed COX-2 at a moderate …
引用总数
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202438221825212331141113111257784552133